Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04388475
Title Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Oblato, Inc.
Indications

glioblastoma

Therapies

OKN-007 + Temozolomide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.